This Article Full Text Full Text (PDF) All Versions of this Article: 24/2/349    most recent 01.ATV.0000110657.67317.90v1 Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Lind, S. Articles by Angelin, B. Search for Related Content PubMed PubMed Citation Articles by Lind, S. Articles by Angelin, B. Related Collections Risk Factors Growth factors/cytokines Lipid and lipoprotein metabolism

(Arteriosclerosis, Thrombosis, and Vascular Biology. 2004;24:349.)
© 2004 American Heart Association, Inc.

Atherosclerosis and Lipoproteins

Growth Hormone Induces Low-Density Lipoprotein Clearance but not Bile Acid Synthesis in Humans

Suzanne Lind; Mats Rudling; Sverker Ericsson; Hans Olivecrona; Mats Eriksson; Birgit Borgström; Gösta Eggertsen; Lars Berglund; Bo Angelin

From the Metabolism Unit (S.L., M.R., S.E., H.O., M.E., B.A.), Center for Metabolism and Endocrinology, Department of Medicine and Molecular Nutrition Unit, Center for Nutrition and Toxicology, Novum; Division of Clinical Chemistry (S.L., G.E., L.B.), Department of Laboratory Medicine; and Pediatric Unit (B.B.), Department of Clinical Sciences, Karolinska Institute at Huddinge University Hospital, Stockholm, Sweden.

Correspondence to Bo Angelin, Center for Metabolism & Endocrinology, M63 Huddinge University Hospital, S-141 86 Stockholm, Sweden. E-mail bo.angelin{at}medhs.ki.se

Objective— Growth hormone (GH) induces hepatic low-density lipoprotein (LDL) receptors and lowers plasma cholesterol. We characterized the influence of GH treatment on plasma LDL clearance in normal humans and investigated the relative role of LDL receptor (LDLR) activity and stimulation of bile acid synthesis in subjects with different LDLR expression.

Methods and Results— Plasma clearance of autologous ¹²⁵I-LDL was measured before and during 3 weeks of treatment with GH (0.1 IU/kg per day) in 9 healthy young males. Plasma LDL cholesterol was reduced by 13% and the fractional catabolic rate of LDL increased by 27%. More marked changes were seen in a patient with hypopituitarism substituted with GH (0.07 IU/kg per day) for 3 months. In a second study, GH dose-dependently reduced LDL cholesterol and increased Lp(a) levels in 3 groups of males: younger and elderly healthy subjects and heterozygous familial hypercholesterolemia (FH). No effect on bile acid synthesis measured by the plasma marker 7-hydroxy-4-cholesten-3-one was observed. In an LDLR-deficient FH homozygote, LDL cholesterol was not affected by GH.

Conclusions— GH treatment reduces plasma LDL cholesterol by inducing LDL clearance. In humans, LDLR expression is a prerequisite for this effect, whereas it is not related to stimulation of bile acid synthesis.

Key Words: insulin-like growth factor-I • low density lipoprotein kinetics • familial hypercholesterolemia • lipoprotein (a)

This article has been cited by other articles:

				A. A. van der Klaauw, T. van der Straaten, R. Baak-Pablo, N. R. Biermasz, H.-J. Guchelaar, A. M. Pereira, J. W. A. Smit, and J. A. Romijn Influence of the d3-Growth Hormone (GH) Receptor Isoform on Short-Term and Long-Term Treatment Response to GH Replacement in GH-Deficient Adults J. Clin. Endocrinol. Metab., July 1, 2008; 93(7): 2828 - 2834. [Abstract] [Full Text] [PDF]

				C. Galman, M. Matasconi, L. Persson, P. Parini, B. Angelin, and M. Rudling Age-induced hypercholesterolemia in the rat relates to reduced elimination but not increased intestinal absorption of cholesterol Am J Physiol Endocrinol Metab, September 1, 2007; 293(3): E737 - E742. [Abstract] [Full Text] [PDF]